Drugs / FSR Peptide
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04473859 | Mar 2008 → Apr 2009 | — | Xequel Bio, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FSR Peptide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04473859 ↗ |
| Modality | Peptide | “FSR Peptide” NCT04473859 ↗ |
| Route | Topical | “FSR peptide will be applied to one punch biopsy.” NCT04473859 ↗ |